| 2NC9 | date | ![]() |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| authors | |||||||||||||||
| compound | source | ||||||||||||||
| symmetry |
| ||||||||||||||
| crystal cell |
| ||||||||||||||
| method | X-Ray Diffraction | resolution | |||||||||||||
| Primary reference | Solution structure of the Hop TPR2A domain and investigation of target druggability by NMR, biochemical and in silico approaches., Darby JF, Vidler LR, Simpson PJ, Al-Lazikani B, Matthews SJ, Sharp SY, Pearl LH, Hoelder S, Workman P, Sci Rep. 2020 Sep 29;10(1):16000. doi: 10.1038/s41598-020-71969-w. PMID:32994435 | ||||||||||||||
| Data retrieval |
![]() |
| View 2NC9 in 3D |
Proteopedia, because life has more than 2D. |
| Structure-derived information |
| Sequence-derived information |
|
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |